Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Missouri for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Missouri only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Missouri (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jaffar Hilli (NPI 1952657462)

Field	Value
Entity Type	Individual
Organization	Jaffar Hilli
Address	One Hospital Drive
City	Columbia
State	MO
ZIP	65212
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	August 2, 2012

Payer Source	Total Paid
Medicare	$1.6M
Medicaid	$0

Key Findings

This provider reports Total Medicare revenue of $1.6M and has no Medicaid billing on file, so operationally JAFFAR HILLI is effectively single-payer with Medicare as the dominant revenue source. The precomputed measure shows the top 3 Medicare codes account for 69.1% of total Medicare revenue, confirming a high concentration of income in a very small set of services.

Revenue is heavily concentrated in a single drug code: J9271 accounts for $836K and 53.2% of the provider’s Medicare revenue. With J9271 making up more than half of Medicare receipts and the top three codes totaling 69.1%, the practice appears operationally dependent on a small number of high-revenue oncology biologics.

The code mix aligns with an infusion-based hematology/oncology practice: high-revenue drug administration (J9271 pembrolizumab $836K; J0897 denosumab $121K; Q5122 pegfilgrastim-apgf $107.7K) alongside chemotherapy administration codes such as 96413 ($57.2K) and add-on infusion codes like 96417 ($7.9K). These patterns indicate routine in-office administration of high-cost therapeutics plus supportive agents and iron infusions (J1439 $98.3K), consistent with a clinic that delivers systemic cancer therapy and related supportive care.

Competitive standing is mixed across specific codes. J9271 ranks #308 of 1841 providers nationally (83th percentile; typical, unremarkable volume for this code), indicating solid but not dominant national positioning for pembrolizumab use, while Q5122 ranks #9 of 239 (97th percentile; notably above typical national volume) and J1439 ranks #63 of 1209 (95th percentile; notably above typical national volume), showing unusually high utilization of pegfilgrastim biosimilar and ferric carboxymaltose relative to peers.

Evaluation-and-management activity is unusually high relative to national peers: 99214 shows 1.3K claims, $98 avg paid/claim, $129K revenue (8.2% of Medicare revenue) and ranks #5433 of 479517 providers nationally (99th percentile; extreme outlier), and 99205 ranks #1071 of 66257 providers (98th percentile; extreme outlier). This combination of high E/M volume for both established and new patient visits suggests either a large active panel or frequent visit cadence tied to ongoing infusion therapy.

Infusion and administration metrics further support high treatment throughput: codes such as 96375 (1.1K claims, $12 avg, $12.6K; ranks 97th percentile; notably above typical), 96360 (209 claims, $25 avg, $5.2K; ranks 97th percentile; notably above typical), 96372 (563 claims, $11 avg, $6.2K; ranks 98th percentile; notably above typical), and 96413 (555 claims, $103 avg, $57.2K; ranks 93th percentile; notably above typical) are all at or above high national percentiles. These signal consistent, high-volume infusion services and multiple-add-on chemotherapy administration per session.

Tenure and stability are evident: NPI enumerated 2012-08-02 (~14 years ago), indicating the provider has been registered long enough to build a sustained referral and treatment base. Given the concentration in a few high-revenue biologics and the absence of Medicaid billing, the practice’s financial performance is closely tied to Medicare policy, drug reimbursement, and infusion service volumes rather than diversified payer mix.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

39 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	22,000	$40	$836K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,320	$100	$129K
J0897	Injection, denosumab, 1 mg	6,720	$20	$121K
Q5122	Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg	1,240	$90	$107.7K
J1439	Injection, ferric carboxymaltose, 1 mg	98,250	$1	$98.3K
J1306	Injection, inclisiran, 1 mg	8,520	$10	$76.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	560	$100	$57.2K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	150	$160	$23.1K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	3,680	$10	$22.1K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	340	$50	$17.1K

Showing 1–10 of 39

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 39 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Missouri Distribution

Jaffar Hilli — 9 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Missouri

Full comparison — all codes billed, vs. state median

39 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	7	40	9,100	$40	$502K
J0897	35	210	2,400	$20	$82.4K
Q5122	1	10	870	$90	$79.7K
J1306	2	10	6,530	$10	$61.5K
Q5106	3	10	5,270	$10	$28.3K
J1439	1	20	21,000	$1	$22.2K
96413	15	160	140	$100	$19.1K
J0885	3	10	2,410	$10	$15.7K
99214	50	8,960	100	$80	$13.9K
99215	648	2,300	30	$110	$6.8K

Showing 1–10 of 39

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jaffar Hilli, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Baycare Medical Group, Inc.	FL	General Practice Physician	$0	$14.9M
Glen Gejerman	NJ	Radiation Oncology Physician	$6.5M	$0
Ali Saberi	FL	Internal Medicine Physician	$5.7M	$0
Bhavesh Balar	NJ	Hematology & Oncology Physician	$4.2M	$0
Kenneth Nahum	NJ	Hematology & Oncology Physician	$3.2M	$0
Frederick Smith	MD	Medical Oncology Physician	$2.7M	$0
May Abdo-matkiwsky	NJ	Hematology & Oncology Physician	$2.6M	$0
Denis Fitzgerald	NJ	Hematology & Oncology Physician	$2.3M	$0
Gurpreet Lamba	VT	Hematology & Oncology Physician	$2.2M	$0
Jeffrey Silberberg	NJ	Hematology & Oncology Physician	$2M	$0

Nearby Providers

Other providers in the same ZIP code as Jaffar Hilli, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Curators Of The University Of Missouri	MO	General Acute Care Hospital	$0	$135.8M
The Curators Of The University Of Missouri	MO	Multi-Specialty Clinic/Center	$0	$40.4M
Curators Of The University Of Missouri	MO	Multi-Specialty Clinic/Center	$0	$31.8M
Curators Of The University Of Missouri	MO	Land Ambulance	$0	$6.2M
Brian Wright	MO	Diagnostic Radiology Physician	$455.9K	$0
Joshua Pagar	MO	Urology Physician	$383.9K	$8K
Patricia Mcghie	MO	Body Imaging Physician	$372.5K	$0
Jella An	MO	Ophthalmology Physician	$336.6K	$0
Christy Waranch	MO	Diagnostic Radiology Physician	$332.3K	$0
Nathan Hesemann	MO	Ophthalmology Physician	$282.5K	$0

Jaffar Hilli — Billing Profile & Reimbursement Data

Sign up for Jaffar Hilli — Billing Profile & Reimbursement Data policy alerts

Jaffar Hilli — Billing Profile & Reimbursement Data

Sign up for Jaffar Hilli — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References